Paul Tudor Jones's INSM Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 195,391 shares of Insmed Incorporated (INSM) worth $20.83 M, representing 0.03% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in INSM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 195,391 shares. Largest reduction occurred in Q3 2025, reducing 132,307 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Insmed Incorporated (INSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Insmed Incorporated (INSM) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +195,391 | New Buy | 195,391 | $106.62 |
| Q4 2025 | -1,703 | Sold Out | 0 | $0.00 |
| Q3 2025 | -132,307 | Reduce 98.73% | 1,703 | $144.01 |
| Q2 2025 | +134,010 | New Buy | 134,010 | $100.64 |
| Q4 2024 | -11,886 | Sold Out | 0 | $0.00 |
| Q3 2024 | +11,886 | New Buy | 11,886 | $73.00 |
| Q1 2024 | -23,044 | Sold Out | 0 | $0.00 |
| Q4 2023 | -2,373 | Reduce 9.34% | 23,044 | $30.99 |
| Q3 2023 | -13,661 | Reduce 34.96% | 25,417 | $25.25 |
| Q2 2023 | -30,180 | Reduce 43.58% | 39,078 | $21.10 |
| Q1 2023 | -3,723 | Reduce 5.10% | 69,258 | $0.02 |
| Q4 2022 | +10,790 | Add 17.35% | 72,981 | $0.02 |
| Q3 2022 | +157 | Add 0.25% | 62,191 | $21.55 |
| Q2 2022 | +16,664 | Add 36.73% | 62,034 | $19.71 |
| Q1 2022 | +6,999 | Add 18.24% | 45,370 | $23.50 |
| Q4 2021 | +38,371 | New Buy | 38,371 | $27.23 |
| Q1 2020 | -19,419 | Sold Out | 0 | $0.00 |
| Q4 2019 | +2,026 | Add 11.65% | 19,419 | $23.89 |
| Q3 2019 | -33,068 | Reduce 65.53% | 17,393 | $17.65 |
| Q2 2019 | +31,432 | Add 165.18% | 50,461 | $25.60 |
| Q1 2019 | +19,029 | New Buy | 19,029 | $29.06 |
| Q2 2018 | -15,066 | Sold Out | 0 | $0.00 |
| Q1 2018 | +6,044 | Add 66.99% | 15,066 | $22.50 |
| Q4 2017 | -26,647 | Reduce 74.71% | 9,022 | $31.15 |
| Q3 2017 | +14,047 | Add 64.97% | 35,669 | $31.20 |
| Q2 2017 | +5,955 | Add 38.01% | 21,622 | $17.16 |
| Q1 2017 | -7,220 | Reduce 31.55% | 15,667 | $17.49 |
| Q4 2016 | -149 | Reduce 0.65% | 22,887 | $13.24 |
| Q3 2016 | -5,127 | Reduce 18.20% | 23,036 | $14.50 |
| Q2 2016 | +6,610 | Add 30.67% | 28,163 | $9.87 |
| Q1 2016 | +21,553 | New Buy | 21,553 | $12.67 |
| Q4 2015 | -18,238 | Sold Out | 0 | $0.00 |
| Q3 2015 | +18,238 | New Buy | 18,238 | $18.59 |
| Q2 2015 | -27,175 | Sold Out | 0 | $0.00 |
| Q1 2015 | +27,175 | New Buy | 27,175 | $20.79 |
Paul Tudor Jones's Insmed Incorporated Investment FAQs
Paul Tudor Jones first purchased Insmed Incorporated (INSM) in Q1 2015, acquiring 27,175 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Insmed Incorporated (INSM) for 35 quarters since Q1 2015.
Paul Tudor Jones's largest addition to Insmed Incorporated (INSM) was in Q2 2026, adding 195,391 shares worth $20.83 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 195,391 shares of Insmed Incorporated (INSM), valued at approximately $20.83 M.
As of the Q2 2026 filing, Insmed Incorporated (INSM) represents approximately 0.03% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Insmed Incorporated (INSM) was 195,391 shares, as reported at the end of Q2 2026.